Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

Neuroprotective Agents for ALS

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Scientists at many institutions are researching to find neuroprotective agents for ALS. While today's guests research focuses on other neurological diseases, he recently wrote a commentary to a published neurology article about ALS research suggesting that the properties of a drug, Taxol should also be considered in animal models researching ALS. In this segment, Dr. Mark Nolan Hill talks with Dr. William Burke about ALS and why Taxol may be a worthwhile drug to examine in animal models as a neuoroprotective agent for ALS.
Recommended
Details
Presenters
Comments
  • Overview

    Scientists at many institutions are researching to find neuroprotective agents for ALS. While today's guests research focuses on other neurological diseases, he recently wrote a commentary to a published neurology article about ALS research suggesting that the properties of a drug, Taxol should also be considered in animal models researching ALS. In this segment, Dr. Mark Nolan Hill talks with Dr. William Burke about ALS and why Taxol may be a worthwhile drug to examine in animal models as a neuoroprotective agent for ALS.
Schedule2 Dec 2024